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DISCUSSION 
•  Symptoms of disseminated 
histoplasmosis usually include 
nonspecific complaints of prolonged 
fever, fatigue, and anorexia.2 




•  40–50% of immunocompromised 
pediatric patients with disseminated 
disease have negative chest x-ray.3 
•  Fungal culture is the gold standard of 
diagnosis.4 
CONCLUSION 
In an immunocompromised patient, 
even without obvious exposure, a fever 
and systemic illness should raise 
concern for disseminated 
histoplasmosis. 
CASE PRESENTATION 
•  10-year-old female presented to PEC with 10 days of 
fever (T-max 103.7 ˚F). 
 
•  Associated symptoms included fatigue, myalgias, 
anorexia. 
 
•  Denied recent travel or significant exposures. 
 
•  Immunizations up to date. 
 
•  History of Juvenile Dermatomyositis managed with 
mycophenolate and methotrexate. 
INTRODUCTION 
•  Histoplasma capsulatum is a dimorphic fungi endemic 
to central and eastern U.S.1 
 
•  The organism is found in soil contaminated by bird or 
bat droppings.1 
 
•  Infection occurs when it is aerosolized and inhaled.1 
 
•  The disease is a self-limited respiratory infection but 
can lead to severe pulmonary or disseminated disease 





granulomas in bone 
marrow biopsy, H&E 
stain 
Rare fungal yeast forms 
consistent with 
Histoplasma capsulatum 




•  Ill-appearing, no petechiae or rash 
•  No erythema or exudate in posterior oropharynx, no cervical or 
inguinal LAD 
•  Lungs clear to auscultation bilaterally  




Viral infection, macrophage activating syndrome, bacterial infection, 








•  CXR: negative for opacifications, or other abnormalities 
•  Blood cultures: no growth 
•  Peripheral smear: leukopenia w/ normal leukocyte morphology 
 
•  Negative autoimmune work-up: ANA, C3/C4, dsDNA, hepatitis 
panel 
 
•  Negative infectious work-up: Respiratory pathogen panel, 
Gastrointestinal pathogen panel, Fungitell, Galactomannan, CMV, 
EBV, Tularemia, Mycoplasma, Bartonella, Brucella, and other tick-
borne illness 
 
•  Positive infectious work-up: Histoplasma urine antigen and 
serum antigen/antibody tests 
 
 
FINAL DIAGNOSIS & TREATMENT 
•  Disseminated Histoplasmosis 
 
•  Completed two-week course of IV amphotericin B while inpatient 
and will continue oral itraconazole for 12 months. 
T: 41.7 ˚C BP: 85/48 HR: 83 RR: 20 SpO2: 97% RA 
WBC: 2.7 ANC: 1100 Hgb: 11.9 Plts: 79 ALT: 69 LDH: 685 
Ferritin: 1643 CRP: 2.46 mg/dl 
